Significance of CD44 gene products for cancer diagnosis and disease evaluation
- 1 October 1992
- journal article
- Published by Elsevier in The Lancet
- Vol. 340 (8827), 1053-1058
- https://doi.org/10.1016/0140-6736(92)93077-z
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Clinical implications of metastatic processThe Lancet, 1992
- Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain.Journal of Biological Chemistry, 1992
- Distinct effects of two CD44 isoforms on tumor growth in vivo.The Journal of Experimental Medicine, 1991
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991
- The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells.The EMBO Journal, 1991
- ALTERNATIVE SPLICING IN THE CONTROL OF GENE EXPRESSIONAnnual Review of Genetics, 1989
- Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types.The Journal of cell biology, 1989
- A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein familyCell, 1989